CSF3 and spontaneous abortion: In the future, more large-sample, multi-center, high-quality RCTs are needed to verify the efficacy and safety of G-CSF treatment for recurrent miscarriage, and to further standardize the administration method, timing, and dosage of G-CSF, providing evidence-based support for the clinical treatment of recurrent miscarriage.